Abzena, a San Diego-based CDMO and CRO focused on bioconjugates and complex biologics, has welcomed Taylor Boyd as its new ...

The European Commission has proposed new legislation to safeguard the supply of critical medicines in the EU by boosting ...

President Donald Trump has withdrawn his nomination of Dave Weldon to lead the CDC, just hours before he was due to appear in ...

Nevertheless, the rise in the Statutory Scheme rate to almost a third of pharma company revenue – which brings the average ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...

Jane Chung, president and chief operating officer at Sutro, is replacing Bill Newell as chief executive as the company starts ...

According to Prof Phil Banfield, chair of BMA council, it had become clear that the centre "no longer has a grip on the ...

Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma, taking its ...

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) had been scheduled to meet to discuss the strains ...

The 5th Medical Device Software Development Summit is your must-attend opportunity to gain actionable strategies, real-world ...

Philadelphia-based Endo sold its international pharma unit to Knight Therapeutics this week for up to $99 million, while ...